SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
March 26, 2020 —
SNMMI Encourages Legislators To Ensure Accessibility to PPE
On Thursday, March 26, the Society of Nuclear Medicine and Molecular Imaging joined the American College of Radiology, the American Society of Radiologic Technologists, the American Registry of Radiologic Technologists, the Nuclear Medicine Technologist Certification Board and the Society of Diagnostic Medical Sonography in calling for an adequate supply of personal protective equipment (PPE).
March 16, 2020 —
Mo-99 Supply Update
On Monday, March 16, SNMMI President Vasken Dilsizian, MD, released the following statement addressing how the COVID-19 pandemic may affect the supply of Mo-99.
March 5, 2020 —
*Latest Update:* SNMMI Identifies NCCI Edit Errors
SNMMI has confirmed that there are incorrect edits in the National Correct Coding Initiative (NCCI) for several of the new and revised CPT codes that went into effect on January 1, 2020.
February 18, 2020 —
SNMMI Hosts FDA Workshop
On Friday, February 21, SNMMI and the FDA will be hosting a workshop entitled "PET Drugs: A Workshop on Inspections Management and Regulatory Issues."
November 15, 2019 —
Good News for Members on CMS PET NCD
After reviewing the NCDs for PET for Myocardial Perfusion and PET for Myocardial Viability, CMS clarified that PET quantitative myocardial blood flow is coverable under these NCDs.